Contrary to popular belief, curing a disease can be more economically valuable than relying on ongoing monthly treatments. Recent findings show that a one-time cure, achieving the same patient outcomes without recurring prescriptions, can offer over twice the financial return. Chief Futurist Brett Winton covers more on The Brainstorm.
|
Tom Rogers, Versant Media senior advisor...
President Donald Trump delivers remarks ...
JPMorgan Chase CEO Jamie Dimon talks wit...
The Investment Committee debate whether ...
Alex Morgan, retired American profession...
Silvio Napoli, Lucid Group CEO, joins 'T...
Venture firms are turning to creators to...
This was a DISASTER! #ytshorts #unsigh...
SpaceX is accelerating its growth trajec...
WSJ’s Damian Paletta explains the challe...
Shopify stock rallied after the e-commer...
CVS Health delivered a strong second-qua...
The New York Times saw its shares plumme...
Eli Lilly delivered impressive second qu...
AMD just delivered record second-quarter...